Research
Research groups
Research grants
PRIMROSE CSF study - A prospective study of the genomic landscape of brain metastasis secondary to breast cancer utilising cell free DNA derived from cerebral spinal fluid.
MAKE 2NDS COUNT (UK)
July 2020 - March 2025
CCP–CANCER UK: Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK) – a prospective companion study for patients with Cancer and COVID-19.
MEDICAL RESEARCH COUNCIL, THE CLATTERBRIDGE CANCER CHARITY (UK)
June 2020 - April 2024
Bench Fees for Atenea Uribe Ojeda (201519967)
AGENCIA NACIONAL DE INVESTIGACIÓN Y DESARROLLO (CHILE)
February 2021 - January 2025
A phase II randomised study of the cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with oestrogen suppression therapy versus oestrogen suppression therapy alone as neoadjuvant therapy in ER-positive intermediate recurrence score primary breast cancer (NEO21-RS)
PFIZER LTD (UK)
July 2018 - June 2022
BELLE-CNS: A proof of concept study of BKM120 in HER2 positive breast cancer with brain metastasis following HER2 directed monoclonal antibody therapy
NOVARTIS PHARMACEUTICALS UK LTD (UK), THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST (UK)
October 2015 - September 2017
Stretching the supply routes: ErbB2 gene amplification and endocytic recycling in metastatic breast cancer
BREAST CANCER NOW (UK)
January 2015 - January 2019